Delivra Health Brands Reports FY2026 Financial Results
Key Highlights
- ➤Net revenue $8,629, down 35.5% from $13,370 in fiscal 2025
- ➤Adjusted EBITDA loss $(1,845), versus $643 profit in fiscal 2025
- ➤Gross profit $3,335, with margin falling to 39% from 51%
- ➤Dream Water® U.S. sales declined $3,912 amid reduced Middle East shipments
- ➤Fiscal 2027 plans target normalized retail ordering and renewed LivRelief™ Infused growth
Expert Statements
Gord Davey, President and Chief Executive Officer of Delivra Health Brands Inc.
“Fiscal 2026 was a challenging year for Delivra Health Brands. The Iran war and related geopolitical uncertainty in the Middle East combined with the impact of tariffs affecting our North American vendors put significant pressure on our sales volumes, input costs and transportation logistics. In addition, we implemented structural changes in our US e-commerce business and LivRelief™ Infused business over the past year to improve Delivra Health's market position and profitability. Finally, the Company launched a number of new products in fiscal 2026 which impacted short-term financial results but are expected to benefit the business in the near to long term. Fortunately, Delivra Health entered fiscal 2026 in a strong financial position, which provided resilience as we navigated these challenges. Our diversified partner network and sales channels also helped the Company to respond as the operating environment evolved. Despite these significant challenges, we are encouraged by the underlying strength of our core business and the continued growth and development of our e-commerce channels in Canada and the United States. We intend to work closely with our local partners to advance our sales initiatives and innovation pipeline. In fiscal 2027, we are taking steps to normalize retail ordering patterns, continue the growth of our e-commerce channels, improve the performance of the LivRelief™ Infused business, and advance our product innovation projects, all with the objective of rebuilding sales volumes and profitability across all Dream Water® and LivRelief™ product lines.”
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer-packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the 12 months ended June 30, 2026 ("fiscal 2026"). The Delivra Health portfolio features innovative brands Dream Water® and LivRelief™, which deliver relief from common health issues such as sleeplessness, chronic pain and anxiety.
"Fiscal 2026 was a challenging year for Delivra Health Brands", said Gord Davey, President and Chief Executive Officer of the Company. "The Iran war and related geopolitical uncertainty in the Middle East combined with the impact of tariffs affecting our North American vendors put significant pressure on our sales volumes, input costs and transportation logistics. In addition, we implemented structural changes in our US e-commerce business and LivRelief™ Infused business over the past year to improve Delivra Health's market position and profitability. Finally, the Company launched a number of new products in fiscal 2026 which impacted short-term financial results but are expected to benefit the business in the near to long term. Fortunately, Delivra Health entered fiscal 2026 in a strong financial position, which provided resilience as we navigated these challenges. Our diversified partner network and sales channels also helped the Company to respond as the operating environment evolved. Despite these significant challenges, we are encouraged by the underlying strength of our core business and the continued growth and development of our e-commerce channels in Canada and the United States. We intend to work closely with our local partners to advance our sales initiatives and innovation pipeline. In fiscal 2027, we are taking steps to normalize retail ordering patterns, continue the growth of our e-commerce channels, improve the performance of the LivRelief™ Infused business, and advance our product innovation projects, all with the objective of rebuilding sales volumes and profitability across all Dream Water® and LivRelief™ product lines."
Get started
Create a free account to read the full story.